Related Experiment Video
Updated: Nov 16, 2025
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
4.4K
Egyptian practical guidance in lipid management 2020
Hesham Salah El Din Taha1, Hala Mahfouz Badran2, Hossam Kandil3
1Department of Cardiology, Faculty of Medicine, Cairo University, 27 Nafezet Sheem El Shafae St Kasr Al Ainy, Cairo, 11562, Egypt. heshsalt@yahoo.com.
Summary
Dyslipidemia significantly contributes to atherosclerotic cardiovascular disease (ASCVD). This guidance simplifies risk assessment and lipid management strategies, including non-statin drugs, to aid physicians in preventing cardiovascular events.
Area of Science:
- Cardiology
- Lipidology
- Preventive Medicine
Background:
- Dyslipidemia is a primary driver of atherosclerotic cardiovascular disease (ASCVD), confirmed by epidemiological and clinical studies.
- Managing serum cholesterol and low-density lipoprotein (LDL) levels is crucial for cardiovascular event prevention.
Purpose of the Study:
- To summarize current risk estimation methods for dyslipidemia.
- To outline recent data on lipid management strategies, including non-statin therapies.
- To enhance physician awareness and facilitate guideline implementation in clinical practice.
Main Methods:
- Review of existing epidemiological and randomized clinical studies on dyslipidemia and ASCVD.
- Analysis of guidelines from various organizations regarding patient risk stratification and management.
- Description of newer, non-statin cholesterol-lowering agents and their indications.
Main Results:
- Dyslipidemia is a well-established risk factor for ASCVD.
- Guidelines provide frameworks for risk assessment and management strategies.
- Non-statin drugs are indicated for secondary prevention in high-risk ASCVD patients.
Conclusions:
- Current guidance offers a user-friendly summary of risk estimation and lipid management.
- The aim is to improve physician understanding and application of lipid management guidelines.
- Effective management of dyslipidemia is key to reducing ASCVD events.
Related Concept Videos
01:18Lipids: Dietary Sources and Requirements
1.5K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.5K
01:26Atherosclerosis III: Management
113
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
113
01:24Overview of Lipid Metabolism
3.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.7K
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
427
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
427
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.1K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
01:15Diabetes: Management and Pharmacotherapy
697
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
697